Fintel reports that on October 17, 2024, Bernstein initiated coverage of Pfizer (NYSE:PFE) with a Market Perform ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.03% of ...

For fiscal 2024, analysts expect PFE to report an EPS of $2.66, up 44.6% from $1.84 in fiscal 2023 . Shares of PFE have ...

Baby Boomers looking to put new money to work may wish to check out the broader basket of dividend stocks while interest ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Pfizer (PFE – Research Report), with a price ...

With valuations growing across the stock market and the biopharma sector, it's only natural for value-sensitive investors to ...

Marcum Wealth LLC lessened its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 5.2% in the 3rd quarter, ...

Leerink Partners analyst David Risinger has maintained their neutral stance on PFE stock ... also maintained a Hold rating on the stock with a $31.00 price target. Based on the recent corporate ...

In the latest market close, Pfizer (PFE) reached $29.08, with a -0.27% movement compared to the previous day. The stock's performance was behind the S&P 500's daily gain of 0.77%. Meanwhile, the Dow ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the ...

On Oct. 6, The Wall Street Journal reported that activist investor group Starboard Value owns a stake in Pfizer (NYSE: PFE) ...